Industry: Biotechnology & medical research

Huawei, Intel among big firms selling patents in June-recorded transactions

Two deals could bring NPE risk but others stem from bankruptcies, buying and selling of business units and company product collaborations

05 July 2024

How new technologies are reshaping IP and deal terms in life sciences transactions

Each speciality comes with its own challenges and risks which shape how deals are negotiated and structured – and there is no ‘one-size fits all’ approach

26 June 2024

UPC grants Abbott a preliminary injunction – including for Ireland

But despite a couple of recent wins, PI applicants have a losing record at the Unified Patent Court

21 June 2024

Watershed moment as preliminary injunction granted in US biosimilar dispute

Regeneron’s PI against Samsung Bioepis in ongoing aflibercept litigation follows several failed attempts to obtain interim bans by biologic patentees

18 June 2024

Three crucial lessons to navigate IP and regulatory devils in medical innovation

Advice for biotech-pharma innovators to manage IP strategy while taking the risky gamble of introducing new drugs or medical devices to market

14 June 2024

Bayer suffers big blow at UK Court of Appeal, clearing path for generic Xarelto launches

The German company remains involved in more than 70 proceedings across 20-plus European countries

28 May 2024

Pfizer unit awarded $108 million for AstraZeneca infringement by Delaware jury

But big money pharma patent damages have a habit of being overturned

21 May 2024

Moderna’s surprise EPO win is a boost for its flagging European patent assertions

But the covid-19 jab maker must overcome several more hurdles to get its hands on a slice of Pfizer/BioNTech’s vaccine revenues

20 May 2024

Amgen’s Sandoz settlement latest of many biosimilar dispute successes

Californian company has been one of the most prolific litigants on both sides of BPCIA disputes

16 May 2024

10x Genomics suffers another reversal of fortunes with German invalidation in NanoString spat

Following buyout by Bruker, NanoString has struck another blow in worldwide patent dispute against its spatial biology rival

13 May 2024